Earnings Feed
Start Free
Home/Filings/4/0001140361-13-025190
4//SEC Filing

REXAHN PHARMACEUTICALS, INC. 4

Accession 0001140361-13-025190

$IRDCIK 0001228627operating
View on SEC.govCompany Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:22 PM ET

Size

9.3 KB

Accession

0001140361-13-025190

Insider Transaction Report

Form 4
Period: 2013-06-11
REXAHN PHARMACEUTICALS, INC.RNN
Hwang Si Moon
Director
Transactions
  • Award

    Stock Options (right-to-buy)

    2013-06-11+60,000→ 60,000 total
    Exercise: $0.50Exp: 2023-06-11→ Common Stock (60,000 underlying)
Holdings

  • Common Stock

    341,198

  • Common Stock

    (indirect: By son)
    7,000

  • Common Stock

    (indirect: By daughter)
    7,000

  • Common Stock

    (indirect: By daughter)
    7,000

  • Stock Options (right-to-buy)

    Exercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]These options vest and become exercisable in full on June 11, 2014.
  • [F2]These options vest and become exercisable in full on June 18, 2013.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001228627

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:22 PM ET
Size
9.3 KB
View on SEC.gov